Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction

Objective The purpose of this study was to explore whether endometrial microbial colonization and plasma cell endometritis are risk factors for adverse pregnancy outcomes, and whether these outcomes are influenced by interactions between interconceptional antibiotics and the micro-flora. Study Desig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2007-10, Vol.197 (4), p.367.e1-367.e6
Hauptverfasser: Tita, Alan T.N., MD, MPH, PhD, Cliver, Suzanne P., BA, Goepfert, Alice R., MD, Conner, Michael, MD, Goldenberg, Robert L., MD, Hauth, John C., MD, Andrews, William W., PhD, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 367.e6
container_issue 4
container_start_page 367.e1
container_title American journal of obstetrics and gynecology
container_volume 197
creator Tita, Alan T.N., MD, MPH, PhD
Cliver, Suzanne P., BA
Goepfert, Alice R., MD
Conner, Michael, MD
Goldenberg, Robert L., MD
Hauth, John C., MD
Andrews, William W., PhD, MD
description Objective The purpose of this study was to explore whether endometrial microbial colonization and plasma cell endometritis are risk factors for adverse pregnancy outcomes, and whether these outcomes are influenced by interactions between interconceptional antibiotics and the micro-flora. Study Design Subgroup analyses of data from a double-blind, randomized, placebo-controlled trial of a course of metronidazole plus azithromycin given every 4 months to women with a prior preterm delivery to prevent recurrent preterm delivery. Endometrial cultures and histology were obtained at randomization and repeated 2 weeks after the first treatment. Fifty-nine on antibiotics versus 65 on placebo had pregnancy outcomes. Prevalence of adverse pregnancy outcomes (pregnancy loss or preterm birth < 37 weeks) was stratified by treatment group and endometrial characteristics. Subgroups were assessed and screened for potential interaction ( P values for significance set a priori at < .01), prior to formal statistical testing for interaction ( P values < .05). Results The prevalence of adverse pregnancy outcome was 62.7% in the presence of endometrial microbial colonization at baseline (any microbe) and 50% in the absence of colonization (RR = 1.25; 99% CI 0.42-3.7). Prevalence of adverse pregnancy outcomes was 61.9% with plasma cell endometritis, and 70.8% without; RR = 0.87 (0.50-1.5). There was a nonsignificant reduction in adverse pregnancy outcome in the absence of Gardnerella vaginalis or Gram-negative rods with RR (95% CI) = 0.60 (0.3-1.2) and 0.66 (0.4-1.2), respectively. In the presence of these microbes, antibiotics appeared to increase adverse outcomes: RR = 1.5 (1.1-2.0) and 1.5 (1.1-2.1), respectively. This reversal of impact represents a crossover interaction. Conclusion Neither baseline endometrial microbial colonization nor plasma cell endometritis were risk factors for adverse pregnancy outcome. However, colonization with specific microbes interacted with antibiotics to increase adverse outcomes.
doi_str_mv 10.1016/j.ajog.2007.06.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68337367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002937807007570</els_id><sourcerecordid>68337367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-2131d90714552e08137941732ec8395a84d112f79a2b9baaace89f51c7f1471b3</originalsourceid><addsrcrecordid>eNp9kk2O1DAQhS0EYpqBC7BAWbFLpmwncYwQ0qjFz0gjsQDWluNUBockDrbTUu-4w9yQk-DQLYFYsHG5rFev7PpMyHMKBQVaXw2FHtxdwQBEAXUBrHlAdhSkyOumbh6SHQCwXHLRXJAnIQxbyiR7TC6okFDKmu3I_X60szV6zKK3aXV9ZueI3rjZ4BKtm9OhnqNtrYvWhCy6bPF4wDluMSmnrLU-fn2VhbW9825dklyPx4AhbbpscSHYdsRMdwf0Af8y-_njfrLGu3Zr_LurNlvHp-RRr8eAz87xknx59_bz_kN--_H9zf76NjclyJgzymknQdCyqhhCQ7mQJRWcoWm4rHRTdpSyXkjNWtlqrQ02sq-oET0tBW35JXl58l28-75iiGqyweA46hndGlTdcC54LZKQnYTpsiF47NXi7aT9UVFQGwo1qA2F2lAoqFVCkYpenN3XdsLuT8l59knw-iTA9MaDRa-CsZjG3lmPJqrO2f_7v_mn3JxRfsMjhsGtPnEIiqrAFKhPG_3tL4BIJpUA_gu65rP3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68337367</pqid></control><display><type>article</type><title>Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tita, Alan T.N., MD, MPH, PhD ; Cliver, Suzanne P., BA ; Goepfert, Alice R., MD ; Conner, Michael, MD ; Goldenberg, Robert L., MD ; Hauth, John C., MD ; Andrews, William W., PhD, MD</creator><creatorcontrib>Tita, Alan T.N., MD, MPH, PhD ; Cliver, Suzanne P., BA ; Goepfert, Alice R., MD ; Conner, Michael, MD ; Goldenberg, Robert L., MD ; Hauth, John C., MD ; Andrews, William W., PhD, MD</creatorcontrib><description>Objective The purpose of this study was to explore whether endometrial microbial colonization and plasma cell endometritis are risk factors for adverse pregnancy outcomes, and whether these outcomes are influenced by interactions between interconceptional antibiotics and the micro-flora. Study Design Subgroup analyses of data from a double-blind, randomized, placebo-controlled trial of a course of metronidazole plus azithromycin given every 4 months to women with a prior preterm delivery to prevent recurrent preterm delivery. Endometrial cultures and histology were obtained at randomization and repeated 2 weeks after the first treatment. Fifty-nine on antibiotics versus 65 on placebo had pregnancy outcomes. Prevalence of adverse pregnancy outcomes (pregnancy loss or preterm birth &lt; 37 weeks) was stratified by treatment group and endometrial characteristics. Subgroups were assessed and screened for potential interaction ( P values for significance set a priori at &lt; .01), prior to formal statistical testing for interaction ( P values &lt; .05). Results The prevalence of adverse pregnancy outcome was 62.7% in the presence of endometrial microbial colonization at baseline (any microbe) and 50% in the absence of colonization (RR = 1.25; 99% CI 0.42-3.7). Prevalence of adverse pregnancy outcomes was 61.9% with plasma cell endometritis, and 70.8% without; RR = 0.87 (0.50-1.5). There was a nonsignificant reduction in adverse pregnancy outcome in the absence of Gardnerella vaginalis or Gram-negative rods with RR (95% CI) = 0.60 (0.3-1.2) and 0.66 (0.4-1.2), respectively. In the presence of these microbes, antibiotics appeared to increase adverse outcomes: RR = 1.5 (1.1-2.0) and 1.5 (1.1-2.1), respectively. This reversal of impact represents a crossover interaction. Conclusion Neither baseline endometrial microbial colonization nor plasma cell endometritis were risk factors for adverse pregnancy outcome. However, colonization with specific microbes interacted with antibiotics to increase adverse outcomes.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2007.06.028</identifier><identifier>PMID: 17904962</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject><![CDATA[Adult ; Anti-Bacterial Agents - administration & dosage ; Antibiotic Prophylaxis - methods ; antibiotics ; Azithromycin - administration & dosage ; Bacterial Infections - drug therapy ; Bacterial Infections - microbiology ; Bacterial Infections - prevention & control ; Double-Blind Method ; endometrial micro-flora ; Endometritis - drug therapy ; Endometrium - microbiology ; Female ; Humans ; interactions or effect modification ; Metronidazole - administration & dosage ; Obstetrics and Gynecology ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Pregnancy Complications, Infectious - microbiology ; Pregnancy Complications, Infectious - prevention & control ; Pregnancy Outcome ; Premature Birth - microbiology ; Premature Birth - prevention & control ; preterm birth]]></subject><ispartof>American journal of obstetrics and gynecology, 2007-10, Vol.197 (4), p.367.e1-367.e6</ispartof><rights>Mosby, Inc.</rights><rights>2007 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-2131d90714552e08137941732ec8395a84d112f79a2b9baaace89f51c7f1471b3</citedby><cites>FETCH-LOGICAL-c409t-2131d90714552e08137941732ec8395a84d112f79a2b9baaace89f51c7f1471b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002937807007570$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17904962$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tita, Alan T.N., MD, MPH, PhD</creatorcontrib><creatorcontrib>Cliver, Suzanne P., BA</creatorcontrib><creatorcontrib>Goepfert, Alice R., MD</creatorcontrib><creatorcontrib>Conner, Michael, MD</creatorcontrib><creatorcontrib>Goldenberg, Robert L., MD</creatorcontrib><creatorcontrib>Hauth, John C., MD</creatorcontrib><creatorcontrib>Andrews, William W., PhD, MD</creatorcontrib><title>Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective The purpose of this study was to explore whether endometrial microbial colonization and plasma cell endometritis are risk factors for adverse pregnancy outcomes, and whether these outcomes are influenced by interactions between interconceptional antibiotics and the micro-flora. Study Design Subgroup analyses of data from a double-blind, randomized, placebo-controlled trial of a course of metronidazole plus azithromycin given every 4 months to women with a prior preterm delivery to prevent recurrent preterm delivery. Endometrial cultures and histology were obtained at randomization and repeated 2 weeks after the first treatment. Fifty-nine on antibiotics versus 65 on placebo had pregnancy outcomes. Prevalence of adverse pregnancy outcomes (pregnancy loss or preterm birth &lt; 37 weeks) was stratified by treatment group and endometrial characteristics. Subgroups were assessed and screened for potential interaction ( P values for significance set a priori at &lt; .01), prior to formal statistical testing for interaction ( P values &lt; .05). Results The prevalence of adverse pregnancy outcome was 62.7% in the presence of endometrial microbial colonization at baseline (any microbe) and 50% in the absence of colonization (RR = 1.25; 99% CI 0.42-3.7). Prevalence of adverse pregnancy outcomes was 61.9% with plasma cell endometritis, and 70.8% without; RR = 0.87 (0.50-1.5). There was a nonsignificant reduction in adverse pregnancy outcome in the absence of Gardnerella vaginalis or Gram-negative rods with RR (95% CI) = 0.60 (0.3-1.2) and 0.66 (0.4-1.2), respectively. In the presence of these microbes, antibiotics appeared to increase adverse outcomes: RR = 1.5 (1.1-2.0) and 1.5 (1.1-2.1), respectively. This reversal of impact represents a crossover interaction. Conclusion Neither baseline endometrial microbial colonization nor plasma cell endometritis were risk factors for adverse pregnancy outcome. However, colonization with specific microbes interacted with antibiotics to increase adverse outcomes.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Antibiotic Prophylaxis - methods</subject><subject>antibiotics</subject><subject>Azithromycin - administration &amp; dosage</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - microbiology</subject><subject>Bacterial Infections - prevention &amp; control</subject><subject>Double-Blind Method</subject><subject>endometrial micro-flora</subject><subject>Endometritis - drug therapy</subject><subject>Endometrium - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>interactions or effect modification</subject><subject>Metronidazole - administration &amp; dosage</subject><subject>Obstetrics and Gynecology</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Pregnancy Complications, Infectious - microbiology</subject><subject>Pregnancy Complications, Infectious - prevention &amp; control</subject><subject>Pregnancy Outcome</subject><subject>Premature Birth - microbiology</subject><subject>Premature Birth - prevention &amp; control</subject><subject>preterm birth</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kk2O1DAQhS0EYpqBC7BAWbFLpmwncYwQ0qjFz0gjsQDWluNUBockDrbTUu-4w9yQk-DQLYFYsHG5rFev7PpMyHMKBQVaXw2FHtxdwQBEAXUBrHlAdhSkyOumbh6SHQCwXHLRXJAnIQxbyiR7TC6okFDKmu3I_X60szV6zKK3aXV9ZueI3rjZ4BKtm9OhnqNtrYvWhCy6bPF4wDluMSmnrLU-fn2VhbW9825dklyPx4AhbbpscSHYdsRMdwf0Af8y-_njfrLGu3Zr_LurNlvHp-RRr8eAz87xknx59_bz_kN--_H9zf76NjclyJgzymknQdCyqhhCQ7mQJRWcoWm4rHRTdpSyXkjNWtlqrQ02sq-oET0tBW35JXl58l28-75iiGqyweA46hndGlTdcC54LZKQnYTpsiF47NXi7aT9UVFQGwo1qA2F2lAoqFVCkYpenN3XdsLuT8l59knw-iTA9MaDRa-CsZjG3lmPJqrO2f_7v_mn3JxRfsMjhsGtPnEIiqrAFKhPG_3tL4BIJpUA_gu65rP3</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Tita, Alan T.N., MD, MPH, PhD</creator><creator>Cliver, Suzanne P., BA</creator><creator>Goepfert, Alice R., MD</creator><creator>Conner, Michael, MD</creator><creator>Goldenberg, Robert L., MD</creator><creator>Hauth, John C., MD</creator><creator>Andrews, William W., PhD, MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071001</creationdate><title>Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction</title><author>Tita, Alan T.N., MD, MPH, PhD ; Cliver, Suzanne P., BA ; Goepfert, Alice R., MD ; Conner, Michael, MD ; Goldenberg, Robert L., MD ; Hauth, John C., MD ; Andrews, William W., PhD, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-2131d90714552e08137941732ec8395a84d112f79a2b9baaace89f51c7f1471b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Antibiotic Prophylaxis - methods</topic><topic>antibiotics</topic><topic>Azithromycin - administration &amp; dosage</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - microbiology</topic><topic>Bacterial Infections - prevention &amp; control</topic><topic>Double-Blind Method</topic><topic>endometrial micro-flora</topic><topic>Endometritis - drug therapy</topic><topic>Endometrium - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>interactions or effect modification</topic><topic>Metronidazole - administration &amp; dosage</topic><topic>Obstetrics and Gynecology</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Pregnancy Complications, Infectious - microbiology</topic><topic>Pregnancy Complications, Infectious - prevention &amp; control</topic><topic>Pregnancy Outcome</topic><topic>Premature Birth - microbiology</topic><topic>Premature Birth - prevention &amp; control</topic><topic>preterm birth</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tita, Alan T.N., MD, MPH, PhD</creatorcontrib><creatorcontrib>Cliver, Suzanne P., BA</creatorcontrib><creatorcontrib>Goepfert, Alice R., MD</creatorcontrib><creatorcontrib>Conner, Michael, MD</creatorcontrib><creatorcontrib>Goldenberg, Robert L., MD</creatorcontrib><creatorcontrib>Hauth, John C., MD</creatorcontrib><creatorcontrib>Andrews, William W., PhD, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tita, Alan T.N., MD, MPH, PhD</au><au>Cliver, Suzanne P., BA</au><au>Goepfert, Alice R., MD</au><au>Conner, Michael, MD</au><au>Goldenberg, Robert L., MD</au><au>Hauth, John C., MD</au><au>Andrews, William W., PhD, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>197</volume><issue>4</issue><spage>367.e1</spage><epage>367.e6</epage><pages>367.e1-367.e6</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Objective The purpose of this study was to explore whether endometrial microbial colonization and plasma cell endometritis are risk factors for adverse pregnancy outcomes, and whether these outcomes are influenced by interactions between interconceptional antibiotics and the micro-flora. Study Design Subgroup analyses of data from a double-blind, randomized, placebo-controlled trial of a course of metronidazole plus azithromycin given every 4 months to women with a prior preterm delivery to prevent recurrent preterm delivery. Endometrial cultures and histology were obtained at randomization and repeated 2 weeks after the first treatment. Fifty-nine on antibiotics versus 65 on placebo had pregnancy outcomes. Prevalence of adverse pregnancy outcomes (pregnancy loss or preterm birth &lt; 37 weeks) was stratified by treatment group and endometrial characteristics. Subgroups were assessed and screened for potential interaction ( P values for significance set a priori at &lt; .01), prior to formal statistical testing for interaction ( P values &lt; .05). Results The prevalence of adverse pregnancy outcome was 62.7% in the presence of endometrial microbial colonization at baseline (any microbe) and 50% in the absence of colonization (RR = 1.25; 99% CI 0.42-3.7). Prevalence of adverse pregnancy outcomes was 61.9% with plasma cell endometritis, and 70.8% without; RR = 0.87 (0.50-1.5). There was a nonsignificant reduction in adverse pregnancy outcome in the absence of Gardnerella vaginalis or Gram-negative rods with RR (95% CI) = 0.60 (0.3-1.2) and 0.66 (0.4-1.2), respectively. In the presence of these microbes, antibiotics appeared to increase adverse outcomes: RR = 1.5 (1.1-2.0) and 1.5 (1.1-2.1), respectively. This reversal of impact represents a crossover interaction. Conclusion Neither baseline endometrial microbial colonization nor plasma cell endometritis were risk factors for adverse pregnancy outcome. However, colonization with specific microbes interacted with antibiotics to increase adverse outcomes.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17904962</pmid><doi>10.1016/j.ajog.2007.06.028</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2007-10, Vol.197 (4), p.367.e1-367.e6
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_68337367
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Anti-Bacterial Agents - administration & dosage
Antibiotic Prophylaxis - methods
antibiotics
Azithromycin - administration & dosage
Bacterial Infections - drug therapy
Bacterial Infections - microbiology
Bacterial Infections - prevention & control
Double-Blind Method
endometrial micro-flora
Endometritis - drug therapy
Endometrium - microbiology
Female
Humans
interactions or effect modification
Metronidazole - administration & dosage
Obstetrics and Gynecology
Pregnancy
Pregnancy Complications, Infectious - drug therapy
Pregnancy Complications, Infectious - microbiology
Pregnancy Complications, Infectious - prevention & control
Pregnancy Outcome
Premature Birth - microbiology
Premature Birth - prevention & control
preterm birth
title Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic–microbial interaction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A51%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20trial%20of%20interconceptional%20antibiotics%20to%20prevent%20preterm%20birth:%20subgroup%20analyses%20and%20possible%20adverse%20antibiotic%E2%80%93microbial%20interaction&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Tita,%20Alan%20T.N.,%20MD,%20MPH,%20PhD&rft.date=2007-10-01&rft.volume=197&rft.issue=4&rft.spage=367.e1&rft.epage=367.e6&rft.pages=367.e1-367.e6&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2007.06.028&rft_dat=%3Cproquest_cross%3E68337367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68337367&rft_id=info:pmid/17904962&rft_els_id=1_s2_0_S0002937807007570&rfr_iscdi=true